Thymidine kinase enzyme selective imaging radiopharmaceutical: Tc-99m(CO)(3)-Ganciclovir
dc.contributor.author | Gedik, B. | |
dc.contributor.author | Teksoz, S. | |
dc.contributor.author | Ichedef, C. | |
dc.contributor.author | Kilcar, A. Y. | |
dc.contributor.author | Medine, E. I. | |
dc.contributor.author | Ucar, E. | |
dc.date.accessioned | 2019-10-27T21:55:39Z | |
dc.date.available | 2019-10-27T21:55:39Z | |
dc.date.issued | 2013 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | The aim of this study is to radiolabel ganciclovir, known as having selective antiviral properties against thymidine kinase, with technetium tricarbonylcore (Tc-99m(CO)(3)(+)) and to investigate the biological behavior of this complex in vitro and in vivo. Commercially provided Ganciclovir (GCV) was radiolabeled with Tc-99m(CO)(3)(+). Initially, optimum radiolabeling conditions were determined by analyzing factors such as temperature, pH and time. Quality control of the radiolabeled compound was performed. The radiolabeling yield was found to be 97%. The Tc-99m(CO)(3)-GCV complex also displayed good in vitro stability during the 24 h period. In vitro cell uptake studies showed that the Tc-99m(CO)(3)-GCV complex is highly uptaken in A-549, PC-3, HeLa cell lines according to the control group Tc-99m(I)-tricarbonyl core. The knowledge gained from in vivo and in vitro studies of Tc-99m(CO)(3)-GCV could contribute to the development of a new HSV1-tk gene imaging agent. | en_US |
dc.description.sponsorship | Ege University (Bornova Izmir, Turkey)Ege University [2010NBE006] | en_US |
dc.description.sponsorship | This study was financially supported by the Ege University Scientific Research Project numbered 2010NBE006 (Bornova Izmir, Turkey). | en_US |
dc.identifier.doi | 10.1524/ract.2013.2003 | |
dc.identifier.endpage | 128 | en_US |
dc.identifier.issn | 0033-8230 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.startpage | 123 | en_US |
dc.identifier.uri | https://doi.org/10.1524/ract.2013.2003 | |
dc.identifier.uri | https://hdl.handle.net/11454/48255 | |
dc.identifier.volume | 101 | en_US |
dc.identifier.wos | WOS:000315178900008 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Walter De Gruyter Gmbh | en_US |
dc.relation.ispartof | Radiochimica Acta | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Thymidine kinase | en_US |
dc.subject | Ganciclovir [Tc-99m(CO)(3)](+) core | en_US |
dc.subject | Radiolabeling | en_US |
dc.title | Thymidine kinase enzyme selective imaging radiopharmaceutical: Tc-99m(CO)(3)-Ganciclovir | en_US |
dc.type | Article | en_US |